Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion type Assertion NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_head.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion description "[Recurrence-free survival (RFS) rates did not differ significantly between patients with the CYP2D6 10/10 genotype (n=40) and patients with the CYP2D6 wild-type (wt)/wt or wt/10 genotype (n=133) or between patients with the CYP2C19 2/2, 2/3, or 3/3 genotypes (n=41) and patients with the CYP2C19 wt/wt, wt/2, or wt/3 genotype (n=132).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_provenance.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion evidence source_evidence_literature NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_provenance.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion SIO_000772 19156902 NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_provenance.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion wasDerivedFrom befree-20150227 NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_provenance.
- NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_assertion wasGeneratedBy ECO_0000203 NP943235.RAcU__kvBO4N6tuMJ9FmAtmh53VZXY8cIElsBpmb1VEw4130_provenance.